The effect of different spectrum of blood infection on the properties of blood clot using Thromboelastometry.
Phase 3
- Conditions
- Health Condition 1: R652- Severe sepsis
- Registration Number
- CTRI/2020/01/022775
- Lead Sponsor
- Indira Gandhi Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.PATIENTS MEETING SEPSIS CRITERIA, SEPTIC SHOCK CRITERIA WITHIN 24 HOURS OF ADMISSIO
Exclusion Criteria
1.PATIENTS ON MEDICATION AFFECTING COAGULATION
2. PATIENTS RECIEVING ANTICOAGULATION THERAPY
3. HISTORY OF DISEASE AFFECTING COAGULATION PROFILE LIKE MALIGNANCY,LIVER FAILURE,RENAL FAILURE.
4.IMPENDING DEATH
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢To Illustrate the changes in clot quality and mass in septic and septic shock patients using TEG. <br/ ><br> <br/ ><br>Timepoint: 60 MIN <br/ ><br>
- Secondary Outcome Measures
Name Time Method By using the changes observed as a marker for hypercoagulable or hypocoagulable state in septic patient, prevent further adverse coagulopathic events. <br/ ><br>To minimize the random use of blood products and use specific therapy.Timepoint: 24 HOURS